Series D brings in an initial $25mm for Intact Vascular
Intact Vascular Inc. (minimally invasive devices for peripheral vascular procedures) raised $25mm through its Series D financing led by Vensana Capital, which was joined by returning shareholders New Enterprise Associates, HIG BioHealth Partners, and Quaker Partners. The company expects another tranche in 2020. Intact Vascular will use the funds to expand sales and marketing activities, and clinical support staffing for its Tack endovascular system for dissection repair following above-the-knee balloon angioplasty. Concurrently, Vesper Medical Inc., which spun out from Intact Vascular in 2016 and is also developing devices for minimally invasive peripheral vascular procedures, raised $37mm in a financing from Vensana Capital, Gilde Healthcare, NEA, and Quaker Partners.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com